The major U.S. equity benchmarks finished mixed on Wednesday, June 24, 2026, with the Dow closing higher while the S&P 500 and Nasdaq ended modestly lower as investors weighed renewed AI-chip volatility against anticipation for Micron’s earnings and the upcoming PCE inflation print. Micron’s (MU) after‑the‑bell blowout fiscal Q3 and bullish AI‑driven outlook helped stabilize sentiment in the semiconductor complex in extended trading as it rose over 14%.
U.S. Equity Index Performance
- Dow Jones Industrial Average: Up .35% closing at 51,848.90 on Wednesday, rebounding from Tuesday’s 0.1% decline.
- S&P 500: Roughly flat closed .10% lower on the day at 7,358.22 after Tuesday’s 1.4% drop.
- Nasdaq Composite: Slightly negative at the close off .43% and closing at 25,476.64 as the chip complex stayed volatile; this follows Tuesday’s 2.2% slide,
Sector Moves and Market Breadth
Tech and communication services lagged again as investors trimmed exposure to high‑beta AI and semiconductor names into a pivotal Micron earnings print. By contrast, defensive pockets and select cyclicals drew incremental flows as traders rotated toward balance sheet strength and cash‑flow visibility.
Key dynamics:
- Semiconductors: Ongoing “AI hangover” after a multi‑month melt‑up left the group vulnerable to profit‑taking ahead of Micron’s numbers.
- Defensives/Staples: Consumer staples and other defensives outperformed again after leading on Tuesday, highlighting a gradual de‑risking under the hood.
- Energy: Lower crude prices now at $69.84/bbl acted as a tailwind for broader risk sentiment but pressured energy equities relative to the tape.
Breadth data show more constructive participation than Tuesday’s tech‑heavy washout, with the Dow’s advance driven by a majority of components in the green while megacap tech remained bifurcated.
Micron’s AI‑Era Earnings Send a Strong Signal
Micron Technology sat squarely at the center of today’s narrative as investors looked to its fiscal Q3 results and guidance for a real‑time read on AI infrastructure demand.
From Micron’s fiscal Q3 2026 release and subsequent coverage:
- Revenue: Micron reported fiscal Q3 revenue of about 41.5 billion dollars, more than quadrupling from roughly 9.3 billion dollars a year earlier, as AI‑driven demand for high‑bandwidth memory and data‑center products surged..
- Profitability: GAAP net income reached roughly 28.2 billion dollars (about 24.67 per diluted share), with non‑GAAP EPS near 25.11 as gross margins expanded sharply on higher prices and improved mix.
- Outlook: Management guided for Q4 revenue around 50 billion dollars, far above the prior‑year period, underscoring confidence in sustained AI‑related demand.
- Capital returns: The board declared a quarterly 0.15‑per‑share cash dividend payable July 21, 2026 to holders of record as of July 6, 2026, reinforcing Micron’s transition into a structurally more cash‑generative phase.
AI Trade: From Euphoria to Scrutiny
Tuesday’s sharp declines in the Nasdaq and semiconductor sector reflected growing unease that AI capex and earnings expectations had disconnected from near‑term fundamentals. By Wednesday, the tone shifted from outright de‑risking to more nuanced stock‑picking around balance sheets, backlog visibility, and exposure to AI data‑center build‑outs.
Macro Backdrop: All Eyes on PCE and the Fed
Wednesday’s session also served as a positioning day ahead of Thursday’s May personal consumption expenditures (PCE) price index, the Fed’s preferred inflation gauge. Futures markets advanced modestly Wednesday evening, with Dow futures up about 0.2% (roughly 120 points) and S&P 500 and Nasdaq 100 futures higher by low‑single‑digit basis points as traders calibrated soft‑landing odds.
Key macro considerations:
- Inflation trajectory: A benign PCE print would reinforce the narrative that disinflation is back on track, giving the Fed more optionality on a 2026–2027 easing path without re‑igniting inflation fears.
- Growth vs. policy: With the U.S. 500 benchmark up over 21% year‑on‑year despite a roughly 1.7% pullback over the last month, equity bulls are effectively betting that earnings growth can outpace any remaining drag from restrictive policy.
- Global cross‑currents: Lower oil prices (Brent around the mid‑70s per barrel and WTI in the low‑70s earlier this week) have eased some stagflation anxiety but also signal caution on global demand..
Positioning around PCE is likely to dictate the next leg for rate‑sensitive sectors (small caps, financials, REITs) and for high‑multiple growth, including AI leaders.
Credit, Commodities, and Cross‑Asset Signals
While the equity tape remains noisy, cross‑asset signals are broadly consistent with a late‑cycle, risk‑on but more selective environment.
- Credit: Spreads remain relatively contained, suggesting no acute stress in corporate funding markets despite recent equity volatility.
- Commodities: Crude prices near multi‑month lows have acted as a quasi‑tax cut for consumers and input‑sensitive industries, helping support cyclicals even as energy equities lag.
- Volatility: The VIX popped more than 12% to about 19.49 on Tuesday’s selloff, underscoring how crowded AI trades can amplify downside, but remains well below crisis levels.
Biotech, Pharma, and Rate‑Sensitive Growth
Even though Wednesday’s headlines were dominated by Micron and AI, the recent rate and inflation backdrop continues to matter for biotech and long‑duration growth.
- Lower yields and contained inflation expectations favor development‑stage biotech and platform‑driven pharma stories that are sensitive to discount‑rate assumptions.
- However, the market’s growing focus on realized cash flows means that later‑stage, near‑commercial names and royalty platforms may see more durable sponsorship than binary clinical‑readout stories..
VP Watchlist Updates
Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, closed at $8.49, +1.92%%.
Eupraxia Pharmaceuticals Inc. (EPRX, $6.25), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”
Modular Medical, Inc. (NASDAQ:MODD, $4.195), a leader in innovative, patient-centric insulin delivery, announced (June 24) that the Pivot™ tubeless insulin patch pump is now commercially available. This marks the start of real-world patient use, and the Company’s transition to a commercial-stage medical device company. As only the second fully electronic, tubeless insulin pump available in the United States, Pivot is designed to make pump therapy simpler to learn and easier to live with. Its removable two-part design and 3 mL reservoir, intuitive interface, and flexible, wearable form factor support everyday activities, such as showering and sports, with no battery recharging required – all while maintaining clinical accuracy and connectivity. “Reaching commercial availability is a transformational milestone that marks Modular Medical’s transition from a development-stage company to a revenue-generating commercial business,” said Jeb Besser, Chief Executive Officer of Modular Medical. “As only the second fully electronic tubeless pump on the U.S. market, Pivot is positioned to serve a large, underserved ‘almost-pumper’ population. With first shipments beginning this week, we are focused on disciplined execution, as we scale adoption and seek to build long-term value for patients and shareholders.”
On (June 4) the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy. This launch follows the Company’s receipt of U.S. Food and Drug Administration (“FDA”) clearance in April 2026 for its Pivot™ insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical’s strategy to expand access to insulin pump technology, particularly among individuals historically underserved by existing solutions. The Company remains on track for commercial launch in the fall of 2026. Pivot is designed for people living with diabetes who rely on daily insulin injections, as well as those who have encountered technological, usability, or cost-related barriers with traditional pump systems. The system emphasizes simplicity and ease of use for the patient and full access to clinical information for the clinician to reduce adoption friction. The PivotPump.com website provides accessible, educational content on insulin pump therapy and highlights the Company’s focus on real-world usability and supporting patients in evaluating and adopting pump-based diabetes care.
Similarweb Ltd. (NYSE: SMWB, $5.16, +3.82%), a leading digital data and analytics company powering critical business decisions, announced (June 15) that it has surpassed $300 million in Annual Recurring Revenue (ARR) and signed two multi-year enterprise contracts, each representing seven-figure ARR commitments. Collectively, these contracts represent approximately $47 million in Total Contract Value to be recognized over the next three years and were signed during the second quarter of 2026.
Loman AI, the leading Voice AI for restaurants, announced (June 3) a partnership with Shift4 (NYSE: FOUR), $44.22, +14.35%), expanding access to its voice AI platform for restaurants using the Shift4 Dine POS system. Loman is already live with hundreds of Shift4-powered restaurants, helping operators capture more revenue, streamline operations, and deliver better guest experiences.
The Sources
- Yahoo Finance – “Stock market today: Dow rises, S&P 500 and Nasdaq slip as AI jitters return ahead of Micron earnings”
https://finance.yahoo.com/markets/live/stock-market-today-dow-rises-sp-500-and-nasdaq-slip-as-ai-jitters-return-ahead-of-micron-earnings-230105138.html - Yahoo Finance – “Micron tops Q3 earnings estimates, offers better‑than‑expected outlook and declares dividend”
https://finance.yahoo.com/technology/article/micron-tops-q3-earnings-estimates-offers-better-than-expected-outlook-and-declares-dividend-113000152.html - CNBC – “Stock market today: live updates for Wednesday, June 24, 2026”
https://www.cnbc.com/2026/06/24/stock-market-today-live-updates.html - CNBC – “Stock market today: live updates for Tuesday, June 23, 2026”
https://www.cnbc.com/2026/06/23/stock-market-today-live-updates.html - CNBC – “Micron stock jumps 9% as soaring prices from memory crunch lead to quadrupling of revenue”
https://www.cnbc.com/2026/06/24/micron-mu-earnings-report-q3-2026.html - Micron Technology – “Micron Technology, Inc. Reports Record Results for the Third Quarter of Fiscal 2026” (official release)
https://investors.micron.com/node/50671/pdf - Nasdaq – “Stock Market News for Jun 24, 2026”
https://www.nasdaq.com/articles/stock-market-news-jun-24-2026 - Trading Economics – “United States Stock Market Index – Quote – Chart”
https://tradingeconomics.com/united-states/stock-market - The Motley Fool – “Stock Market Today, June 24: Stocks Gain at Midday Ahead of Micron’s Earnings”
https://www.fool.com/coverage/stock-market-today/2026/06/24/stock-market-today-june-24-stocks-gain-at-midday-ahead-of-micron-s-e/ - 24/7 Wall St – “Stock Market Live June 24, 2026: S&P 500 (SPY) Attempting to Regain Momentum”
https://247wallst.com/investing/2026/06/24/stock-market-live-june-24-2026-sp-500-spy-attempting-to-regain-momentum/
Stay Updated with Vista Partners
Subscribe to receive market insights, investing ideas, and the latest updates directly in your inbox.
